HeartSciences (HSCS) Other financing activities (2022 - 2025)
HeartSciences' (HSCS) quarterly Other financing activities came in at -$1.9 million in Q2 2025, down 10826.38% on a QoQ basis from $17250.0 in Q3 2022.
HeartSciences (HSCS) Other financing activities (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has 2 years of Other financing activities data on file, last reported at -$1.9 million in Q2 2025.
- Quarterly Other financing activities changed N/A year-over-year to -$1.9 million in Q2 2025, while the trailing twelve-month figure through Apr 2025 was -$1.9 million (changed N/A YoY) and the FY2024 annual result came in at $334249.0, up 1837.68% from the prior year.
- Other financing activities retreated to -$1.9 million in Q2 2025, from $17250.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $17250.0 in Q3 2022 to a low of -$1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | HeartSciences | 6.54 Mn | 4.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -1.85 Mn |
| Apr 30, 2025 | -1.85 Mn |
| Jul 31, 2022 | 17,250.00 |
| Jul 31, 2022 | 17,250.00 |